fashion -WSS

fashion

author：hotspot 2025-10-02 12:32:18 - browse：38

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

In other words, a lot like the content below. I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate.

This week: A deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences and its entirely ridiculous Alzheimer’s drug candidate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Covid vaccines: Private market messier than government rollout

focus

WSS

FDA seeks to regulate lab

Did you have Obamacare on your GOP debate bingo card?

Intercept Pharmaceuticals sells itself for less than $1 billion

Making AI in medicine accessible to smaller, and rural hospitals

Sanofi strikes deal with Novavax, boosting the vaccine maker

Medicaid, Medicare dual

focus

fashion

focus

Walensky prepares to leave CDC — and Congress — behind

Listen: Who gets the credit for GLP

Activists slam private health insurers over coverage restrictions

Address the ethical violations that led to 'Three Identical Strangers'

United colonoscopy coverage change 'may cost lives,' doctors say

WHO recommends dropping component of many flu vaccines

Anesthesiologist group: stop taking Ozempic before surgery

Medicare drug price negotiation program allowed for now

Trump demands the U.S. pay no more for drugs than other countries … again

Readout LOUD podcast: What to know about H5N1 bird flu

hotspot

Sudafed saga points to U.S. issues with evaluating older drugs

Would Medicare drug price negotiations stall in a shutdown?

Elevance, private equity launch primary care company

Why do women spend more than men on medical expenses?

Intercept Pharmaceuticals sells itself for less than $1 billion

Paxlovid should be available without a positive Covid test

leisure time

focus

explore

explore